Tags

Type your tag names separated by a space and hit enter

Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?

Links

  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    HeartDrug Research Laboratories, Johns Hopkins University, Towson, MD 21204, USA. heartdrug@aol.com

    ,

    Source

    MeSH

    Angiotensin II Type 1 Receptor Blockers
    Angiotensin-Converting Enzyme Inhibitors
    Antihypertensive Agents
    Benzimidazoles
    Benzoates
    Blood Pressure
    Clinical Trials, Phase IV as Topic
    Drug Therapy, Combination
    Humans
    Hypertension
    Ramipril
    Randomized Controlled Trials as Topic
    Stroke
    Telmisartan
    Treatment Outcome

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    18936537

    Citation

    Serebruany, Victor L., et al. "Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit Beyond Blood Pressure Lowering?" Cerebrovascular Diseases (Basel, Switzerland), vol. 26, no. 5, 2008, pp. 563-4.
    Serebruany VL, Atar D, Hanley DF. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? Cerebrovasc Dis. 2008;26(5):563-4.
    Serebruany, V. L., Atar, D., & Hanley, D. F. (2008). Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? Cerebrovascular Diseases (Basel, Switzerland), 26(5), pp. 563-4. doi:10.1159/000164555.
    Serebruany VL, Atar D, Hanley DF. Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit Beyond Blood Pressure Lowering. Cerebrovasc Dis. 2008;26(5):563-4. PubMed PMID: 18936537.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? AU - Serebruany,Victor L, AU - Atar,Dan, AU - Hanley,Dan F, Y1 - 2008/10/21/ PY - 2008/10/22/pubmed PY - 2009/1/24/medline PY - 2008/10/22/entrez SP - 563 EP - 4 JF - Cerebrovascular diseases (Basel, Switzerland) JO - Cerebrovasc. Dis. VL - 26 IS - 5 SN - 1421-9786 UR - https://www.unboundmedicine.com/medline/citation/18936537/Telmisartan_and_stroke_reduction_in_the_ONTARGET_trial:_benefit_beyond_blood_pressure_lowering L2 - https://www.karger.com?DOI=10.1159/000164555 DB - PRIME DP - Unbound Medicine ER -